Prodrugs are pharmacologically inactive compounds that undergo metabolic conversion within the body to release an active drug. This strategy is often employed to enhance the bioavailability, selectivity, or solubility of a drug, ultimately improving its therapeutic efficacy and reducing side effects. In the realm of chemotherapy, prodrugs play a crucial role, as they can be designed to target cancer cells more selectively, thereby minimizing damage to healthy tissues.
